Global Coalition on Aging and Alzheimer’s Disease International Call on Countries to Foster Innovation in Dementia Treatment, Prevention, and Care as Global Prevalence Skyrockets

Dementia Innovation Readiness Index Issues Call-to-Action for Argentina, Brazil, China, India, and Saudi Arabia to Prioritize National Plans, Earlier Detection and Diagnosis, Quality Care, and Awareness Campaigns

(Chicago – July 27, 2018) – Today, the Global Coalition on Aging (GCOA) and Alzheimer’s Disease International (ADI) will present findings from the 2018 Dementia Innovation Readiness Index during ADI’s 33rd Conference at McCormick Place in Chicago. The Index analyzes – for the first time ever – the readiness of countries to develop and deploy dementia solutions into their healthcare, policy and social frameworks. This year’s Index evaluates Argentina, Brazil, China, India, and Saudi Arabia. On a 0-10 scale, with 10 being the highest in terms of innovation readiness, scores were as follows: Argentina – 5.3, Brazil – 5.0, China – 6.1, India – 5.1, and Saudi Arabia – 5.9.

Michael W. Hodin, PhD, CEO of GCOA said, “The Dementia Innovation Readiness Index provides leaders across these five countries a comprehensive look into the critical levers that lend to the facilitation of innovation in dementia prevention, treatment and care.

“Governments, NGOs, academia, and industry all have important roles to play as Alzheimer’s and other forms of dementia threaten to become the fiscal nightmare of the 21st century. Even in these countries with younger populations, preparation for the onslaught of dementia that comes with the aging of society cannot wait, and innovation is the key.”

The Index evaluates innovation readiness across 10 categories and identifies specific opportunities and challenges to promote innovation. Among the countries profiled this year, the 65+ population is highest in Argentina at 11.6% and lowest in Saudi Arabia at 3.3%. In comparison, 17.9% of the G7 countries’ population is over 65. And yet, developing countries will be home to nearly 70% of people with dementia by 2050 as the result of population aging.

Paola Barbarino, CEO of ADI said, “The projected increases in the prevalence of dementia around the world present massive health and financial challenges not only for governments and societies, but also individuals, families, and communities.

“People with dementia need early diagnosis, clear care pathways, access to skilled caregiving, and, most importantly, they need their voices to be heard. We encourage leaders in these five countries to use the Index as a wake-up call and roadmap for implementing dementia plans, developing comprehensive funding strategies for research, and raising awareness of dementia across the board.”

The Index found that, although Argentina, Brazil, China, India, and Saudi Arabia have younger populations than G7 countries, they face many of the same barriers to dementia innovation, including limited public leadership and funding, uneven access to high-quality care, and difficulty with early, accurate diagnosis. However, because of their relative youth, these countries lack focus on – and even recognition of – issues related to dementia. Further, the barriers to innovation are exacerbated by resource limitations including, in some cases, extreme poverty.

Huali Wang of the Peking University Institute of Mental Health, China said, “One challenge we must overcome in China is the wide variability in levels of care people receive based on where they live.

“While people living in certain urban areas receive high-quality care, those in rural areas and villages may struggle to receive timely diagnosis and appropriate care.”

The Index’s assessments of the five countries finds that only Argentina has a national dementia plan, which is a program led by Programa de Atención Médica Integral (PAMI) – the Argentine agency responsible for elder care. However, some regional and local areas with rapidly aging populations – such as Tucumán, Argentina, and Kerala, India – are taking the initiative to prioritize and respond to dementia, providing a possible model for larger-scale innovation.

Dr. Ricardo Allegri, Institute for Neurological Research (FLENI), Argentina said, “While it’s encouraging to see local efforts in Argentina, the country also needs a sustained commitment from the national government to promote dementia innovation – and the funds to back it up.”

Other key findings from the Index include:

  • Under-diagnosis is a barrier to fully understanding and treating dementia. Better diagnostic tools and healthcare professionals specializing in geriatrics and dementiawill be critical for ensuring countries can adequately address the individual and societal burden brought by Alzheimer’s and other dementias. In Brazil, for instance, community health workers are trained to identify signs of dementia and refer patients to specialists.
  • The regulatory environment has been slow to evolve with the urgency of the disease. Well-funded and efficient regulatory agencies must be prioritized to ensure therapiescan reach people with dementia in a timely manner.
  • The business community is not integrated into strategies to provide solutions for dementia and should be encouraged and incentivized to bring innovations in medicines and new care models, including maximizing the potential of technology and data.
  • As seen in India, prevention campaigns can serve as an effective and cost-efficient strategy to raise awareness and help the general public and healthcare providers better prepare for the projected increases in dementia.
  • Planning now will ensure these countries with younger populations are prepared for the coming demographic shift. For instance, Saudi Arabia, with currently only 3.3% of its population over 65, has a unique opportunity to innovate now so that in 20 years, solutions that lessen or eliminate the burden of dementia will already be in place.

Index findings are based on an expansive set of survey research, data analysis, and interviews with dozens of experts and representatives from each of the countries studied. These experts represent thousands of stakeholders in the fight against dementia and provide nuanced insights on both common themes and country-specific needs. This year’s Index expands on the first edition of the Index, published in 2017, which focused on G7 countries.

In addition, today GCOA and ADI released the Dementia Innovation Readiness Index: G7 Progress Report, highlighting notable progress since the initial Index was published last year. These developments include an unprecedented level of investment in dementia research by the U.S. government, a commitment from Canada to create a national dementia plan, and the launch of innovative workforce recruitment models in Germany and Japan.

“Policymakers should take a close look at both the 2018 Index and the G7 progress report. They go beyond reporting and provide clear, actionable steps to ensure that people with dementia and their families can get the support they deserve – today, tomorrow, and 10 years from now,” said Lenny Shallcross, Executive Director of the World Dementia Council. “These reports have essential information that can help leaders to design and implement real, powerful solutions for the oncoming dementia crisis.”

The 2018 Dementia Innovation Readiness Index and the G7 Progress Report will be presented today at 5:45 p.m. alongside a panel of experts at the 33rd Annual Alzheimer’s Disease International Conference in Chicago. Speakers will include:

  • Michael Hodin, PhD, CEO, Global Coalition on Aging
  • Chris Lynch, Policy, Communications and Publications Director and Deputy CEO, Alzheimer’s Disease International
  • Mary Alexander, Vice President of Strategic Partnerships and Healthcare Integration, Home Instead Senior Care
  • Ricardo Allegri, Institute for Neurological Research(FLENI)
  • Meera Pattabiraman, Chairperson, Alzheimer’s and Related Disorders Society of India
  • André Trottier, Senior International Health Policy Leader, Roche

The session is open to the media.

CONTACT

Melissa Mitchell Executive Director
Global Coalition on Aging
[email protected]
+1 646 404 1149

Jake Hauritz
Alzheimer’s Disease International
[email protected]
+61 478 128 268

Kate Elliott
Alzheimer’s Disease International
[email protected]
+00 44 7779 870982

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.